US BROKER MOVES: EFX upgraded at Rothschild Redburn; LMB downgraded at JPMorgan

• Equifax (EFX) upgraded from Neutral to Buy w/ USD 235.00 PT (prev. USD 214.00) at Rothschild Redburn
• InnovAge Holding (INNV) upgraded from Sector Weight to Overweight w/ USD 13.00 PT at KeyBanc
• O-I Glass (OI) upgraded from Neutral to Buy w/ USD 9.00 PT (prev. USD 8.00) at Citi
• Portland General Electric (POR) upgraded from Equal Weight to Overweight w/ USD 58.00 PT at Wells Fargo
• TIC Solutions (TIC) upgraded from Underweight to Neutral w/ USD 11.00 PT (prev. USD 9.00) at JPMorgan
• Ternium (TX) upgraded from Equalweight to Overweight w/ USD 65.00 PT (prev. USD 55.00) at Morgan Stanley

• Bowman Consulting (BWMN) downgraded from Neutral to Underweight w/ USD 43.00 PT (prev. USD 40.00) at JPMorgan
• Frontline (FRO) downgraded from Hold to Sell at DZ Bank
• Limbach (LMB) downgraded from Neutral to Underweight w/ USD 50.00 PT (prev. USD 60.00) at JPMorgan
• Ternium (TX) downgraded from Buy to Hold w/ USD 55.00 PT (prev. USD 53.00) at HSBC

• Accel Entertainment (ACEL) initiated Equal Weight w/ USD 14.00 PT at Wells Fargo
• Amarin (AMRN) initiated Underweight w/ USD 13.00 PT at JPMorgan
• BBNX (BBNX) initiated Market Perform at William Blair
• Builders FirstSource (BLDR) initiated Market Perform at Citizens
• Emergent BioSolutions (EBS) initiated Underweight at JPMorgan
• Eldorado Gold (EGO) initiated Buy w/ USD 50.00 PT at Jefferies
• Faeth Therapeutics (FTH) initiated Buy w/ USD 56.00 PT at Needham
• Hecla Mining (HL) initiated Hold w/ USD 22.00 PT at Jefferies
• IAMGOLD (IAG) initiated Buy w/ USD 24.00 PT at Jefferies
• ImageneBio (IMA) initiated Buy w/ USD 28.00 PT at H.C. Wainwright
• Immuneering (IMCR) initiated Overweight w/ USD 50.00 PT at JPMorgan
• Matthews International (MATW) initiated Hold w/ USD 24.00 PT at Truist Securities
• MongoDB (MDB) initiated Outperform w/ USD 525.00 PT at Evercore ISI
• Nektar Therapeutics (NKTR) initiated Neutral w/ USD 65.00 PT at JPMorgan
• Nuvation Bio (NUVB) initiated Overweight at Cantor Fitzgerald
• Solid Biosciences (SLDB) initiated Buy w/ USD 20.00 PT at Truist Securities
• SpaceX (SPCX) initiated Sell w/ USD 100.00 PT at DZ Bank
• Stoke Therapeutics (STOK) initiated Overweight w/ USD 40.00 PT at JPMorgan
• Tandem Diabetes Care (TNDM) initiated Outperform at William Blair
• VMRK (VMRK) initiated Overweight w/ USD 72.00 PT at Wells Fargo
• Select Water Solutions (WTTR) initiated Overweight w/ USD 24.00 PT at JPMorgan

A standard daily broker moves sweep: heavy on initiations, light on ratings changes, and skewed toward small and mid caps where single-note coverage carries more weight. The one genuine signal in the list is the split call on Ternium, upgraded at one house and downgraded at another on the same session, a divergence that in past episodes of this kind has flagged genuine disagreement on the steel and iron-ore outlook rather than noise, and tends to resolve only when the commodity tape or the next set of results arbitrates. The Jefferies initiations across the gold and silver miners read as a sector call dressed as single-stock coverage, a pattern that usually precedes a desk building a thematic book rather than idiosyncratic conviction on each name. JPMorgan's cluster of healthcare initiations, mostly cautious on the smaller biotech names and constructive on a select few, fits the established pattern of new coverage being used to sort a subsector rather than to call it outright. For the upgrades that matter to index desks, the Equifax move at Rothschild Redburn is the one with benchmark weight behind it, though single-analyst changes at that market cap have historically faded within sessions absent corroborating estimate revisions. What typically separates the durable moves from the one-day ones is whether price-target changes come with model revisions, and that detail is not visible in a roundup of this kind.